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Abstract
On September 27, 2015 the 20th annual Alcohol and Immunology Research Interest Group 
(AIRIG) meeting was held as a satellite symposium at the annual meeting of the Society for 
Leukocyte Biology in Raleigh, NC. The 2015 meeting focused broadly on adverse effects of 
alcohol and alcohol-use disorders in multiple organ systems. Divided into two plenary sessions, 
AIRIG opened with the topic of pulmonary inflammation as a result of alcohol consumption, 
which was followed by alcohol’s effect on multiple organs, including the brain and liver. With 
presentations showing the diverse range of underlying pathology and mechanisms associated with 
multiple organs as a result of alcohol consumption, AIRIG emphasized the importance of 
continued alcohol research, as its detrimental consequences are not limited to one or even two 
organs, but rather extend to the entire host as a whole.
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Introduction
A study conducted by the Centers for Disease Control and Prevention reports approximately 
1 in 10 deaths among working adults from the years 2006–2010 was due to excessive 
alcohol use (Centers for Disease Control and Prevention, 2014). Furthermore, alcohol-abuse 
mortalities remain as one of the leading preventable deaths (Centers for Disease Control and 
Prevention, 2014). Acute or chronic alcohol use can drastically increase patients’ 
susceptibility to multiple co-morbidities, including asthma, lung injury, liver disease or 
injury, and neuronal dysfunctions (Crews, Zou, & Qin, 2011; Kim et al., 2001; Teng & 
Molina, 2014; Ware et al., 2007; Wyatt et al., 2012; Yeligar, Machida, Tsukamoto, & Kalra, 
2009). Due to the critical importance of understanding these alcohol-attributed pathologies, 
the Alcohol and Immunology Research Interest Group (AIRIG) made these topics the basis 
of the 2015 meeting.
The AIRIG satellite symposium was divided into two plenary sessions, each with a distinct 
focus: the first on the effects of alcohol use on pulmonary inflammation and repair 
mechanisms following lung injury and the second on multiple-organ responses to alcohol 
exposure, including the brain and the liver. Fostering collaborative relationships and 
promoting scientific discourse among alcohol researchers remains critical to bridge gaps in 
knowledge in such an expansive field while opening new avenues for potentially 
unrecognized treatment options for patients suffering from exacerbated symptoms as a result 
of alcohol abuse. Only with symposia, such as the AIRIG satellite meeting at the Society for 
Leukocyte Biology’s conference, can those important relationships not only be created but 
also more importantly sustained into the future.
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Alcohol and the lung
Dr. Elizabeth J. Kovacs, formerly at Loyola University Chicago and now at the University of 
Colorado Denver, opened the 2015 AIRIG meeting with words of welcome, admiration, and 
respect for the many alcohol researchers present and ready to both share their own data and 
learn about new advancements in the field of alcohol research. This was followed by the first 
plenary session chaired by Dr. Brenda Curtis (formerly at Loyola University Chicago and 
now at the University of Colorado Denver) and Michael Price (University of Nebraska 
Medical Center), where researchers presented their work on the effects of alcohol on 
pulmonary inflammation in a variety of disease states. Dr. Daniel G. Remick of Boston 
University opened the session discussing how alcohol ingestion acts as an asthma trigger. 
Asthma affects 300 million people worldwide and, of those, 250,000 die each year from the 
disease (World Health Organization, 2016). Therefore, Dr. Remick and his group utilized a 
standard murine model of asthma using cockroach allergen (CRA), which requires an initial 
immunization of CRA followed by a challenge of CRA to induce the asthmatic disease state. 
Asthma induction was characterized histologically by an inflammatory infiltrate into the 
bronchoalveolar lavage (BAL) fluid and by symptomatically utilizing whole body 
plethysmography to show airway hyper-reactivity after CRA challenge (Kim et al., 2001). 
Interestingly, previous work showed that alcohol consumption actually suppresses 
pulmonary inflammation resulting from asthma or pneumonia (Oldenburg, Poole, & Sisson, 
2012). However, this was found to be true only following episodes of chronic alcohol 
exposure. The CDC reported that alcohol is the most widely abused drug among the youth 
population in the United States, with most alcohol consumption occurring in a binge pattern 
(Centers for Disease Control and Prevention, 2014). Therefore, the question was posed 
whether binge alcohol drinking could act as an asthma trigger in CRA-sensitized mice. Dr. 
Remick reported that a binge alcohol paradigm given to CRA-sensitized mice acted as an 
asthmatic trigger, increasing mucus production in the lung, hyper-reactivity, BAL 
inflammatory cell infiltrate, and elevated cytokine levels of IL-5, IL-13, and IL-4 in lung 
tissue homogenates just 30 min after gavage with alcohol (Bouchard et al., 2012). Binge 
alcohol consumption triggering an asthmatic episode was not found to be due to mast cell 
degranulation, but rather was due to increased leukotrienes production. Preliminary data 
suggested that a leukotriene receptor antagonist would decrease the asthma-like pulmonary 
inflammation induced by acute alcohol ingestions in CRA-sensitized mice.
Dr. Samantha Yeligar from Emory University presented her work focusing on alcohol abuse 
impairing lung function leading to increased risk of respiratory infection in mice. Phagocytic 
dysfunction of alveolar macrophages (AMs) and thus impaired bacterial clearance after 
chronic alcohol abuse is a consequence of AMs undergoing a feed-forward loop of oxidative 
stress, involving reactive oxygen species (ROS), TGF-β, and nicotinamide adenine 
dinucleotide phosphate (NADPH) oxidases (Mehta, Yeligar, Elon, Brown, & Guidot, 2013; 
Yeligar et al., 2009). However, down-regulation of the NADPH oxidases (Nox) 1, 2, and 4 
via peroxisome proliferator-activated receptors (PPAR) γ ligands, such as pioglitazone 
(PIO), reduce oxidative stress. Studies were performed in a mouse model of chronic alcohol 
consumption in which mice were give ethanol (20% weight/volume) in drinking water for 12 
weeks. PIO (10 mg/kg/day) was given by oral gavage during week 12 to determine whether 
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this PPAR-γ ligand attenuated alcohol-induced AM dysfunction by down-regulating Nox 
proteins and subsequently decreasing AM oxidative stress. Dr. Yeligar showed that PIO 
administration activated PPAR-γ, which acts to down-regulate alcohol-induced increases in 
Nox1, 2, and 4. Down-regulation of the Nox proteins led to reversal of ethanol’s detrimental 
effects in AMs by decreasing oxidative stress, increasing mitochondrial oxygen consumption 
rates, and increasing phagocytic capacity. Therefore, therapeutic intervention with PIO or 
other PPAR-γ ligands during chronic alcohol-use disorders could potentially reduce patient 
susceptibility to respiratory infections.
Lauren Poole, a graduate student from the laboratory of Dr. Gavin Arteel at the University of 
Louisville School of Medicine, shared her studies on the role of plasminogen activator 
inhibitor-1 (PAI-1) in alcohol-mediated acute lung injury (ALI).
Alcohol use continues to be a major risk factor in the development of acute respiratory 
distress syndrome (ARDS), the most severe form of acute lung injury (ALI). Previous 
studies have demonstrated that ARDS occurs 3.7 times more frequently in people meeting 
the diagnostic criteria for alcohol-use disorders (Moss, Bucher, Moore, Moore, & Parsons, 
1996; Ritzenthaler, Roser-Page, Guidot, & Roman, 2013). Excessive alcohol exposure can 
damage target organs via mechanisms including inflammation, oxidative stress, and/or tissue 
remodeling. Lauren’s work focused on the role of pulmonary transitional tissue remodeling 
occurring after acute injury, specifically how PAI-1 is upregulated during this tissue 
remodeling phase of ALI. A previous study has shown that heightened concentrations of 
PAI-1 in circulation correlate with increased mortality after lung injury (Ware et al., 2007). 
PAI-1 was also associated with enhanced inflammation and fibrosis in other models of ALI 
(Arndt, Young, & Worthen, 2005). Utilizing a mouse model of endotoxemia-induced ALI, 
Lauren showed that chronic alcohol feeding enhanced ALI. Enhanced ALI after chronic 
alcohol consumption was accompanied by elevated chemokines, macrophage inflammatory 
protein- (MIP) 2, and keratinocyte chemoattractant (KC). Interestingly, knockout of PAI-1 
attenuated both the pulmonary damage and exaggerated expression of chemokines seen in 
alcohol-exposed mice given liposaccharides. These results suggest that PAI-1 is critical in 
mediating the enhanced pulmonary damage seen in ALI following chronic alcohol exposure, 
which provides insight into the mechanisms behind which alcohol damages remote organs 
such as the lung.
Dr. Ellen L. Burnham, from the University of Colorado Denver, presented her work on the 
connection between acute respiratory distress syndrome (ARDS) and alcohol-use disorders. 
She showed that elevated activity of xanthine oxidoreductase (XOR) in the lung triggered 
pulmonary oxidative stress. XOR expressed in AMs produces ROS along with uric acid. 
Both ROS and uric acid work as a danger signal and can induce a strong inflammatory 
response leading to lung fibrosis (Gasse et al., 2009; Wright et al., 2004). It has been 
suggested that alcohol metabolism contributes to oxidative stress via XOR activity. Dr. 
Burnham and her group were able to show that not only are there higher levels of uric acid 
in the BAL fluid from patients with an alcohol-use disorder (AUD), but also that the AMs 
obtained from the BAL fluid express more XOR protein. These observations accompanied 
data showing enhanced XOR activity in both BAL fluid and serum of patients with AUDs. 
To further expand upon the findings of elevated XOR activity in subjects with AUD, XOR 
Cannon et al. Page 4
Alcohol. Author manuscript; available in PMC 2017 August 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
activity was examined in patients with ARDS. Patients with ARDS demonstrated increased 
XOR activity in both BAL cells and serum compared with healthy controls. Additionally, 
when XOR activity in BAL fluid obtained from ARDS patients was compared to that of 
healthy patients with AUDs, BAL cell XOR activity was similar between AUD subjects and 
ARDS patients, but substantially higher than in healthy controls. Together, these data point 
to a potential additive impact of AUDs on ARDS.
Ending the morning session, Dr. Todd A. Wyatt, from the University of Nebraska Medical 
Center, shared his work on the existent co-morbidity of impaired lung repair and function 
resulting from combined AUDs and cigarette smoking. Among AUD-positive subjects, 90–
95% also smoke cigarettes (Patten, Martin, & Owen, 1996; Sapkota & Wyatt, 2015). 
Previous work has shown that the alcohol consumption combined with exposure to cigarette 
smoke resulted in decreased mucociliary clearance, increased detachment of ciliated cells, 
impaired wound healing, and enhanced lung inflammation (Elliott, Sisson, & Wyatt, 2007; 
Wyatt et al., 2012). Surprisingly, under the paradigm of combined alcohol and cigarette 
exposure, Dr. Wyatt and his group found that several anti-microbial and T-cell chemotactic 
cytokines in mouse whole-lung lavage were decreased when compared to that of either 
exposure alone. They utilized the Meadows-Cook ad libitum alcohol feeding model 
combined with the Teague whole-body smoke exposure system in their studies. Many 
chemokines (CXCL4, CCL17, CCL19, CCL24, CCL25, CCL27), cytokines (IL-4, IL-10), 
and some growth factors and hormones (3, IGFBP-5, IGFBP-6, leptin, SCF) were 
significantly reduced in lavage fluid of mice receiving combined insult of alcohol and 
cigarette smoke. Together these data suggest that the combination of smoking cigarettes and 
drinking alcohol can alter the cytokine response, which then can modulate the lung repair 
processes that would otherwise occur in exposure to either alcohol or smoke alone.
Alcohol and multi-organ responses
The second plenary session was chaired by graduate students Tasha Barr, from the 
laboratory of Dr. Ilhem Messaoudi at the University of California Riverside, and Niya 
Morris, from the laboratory of Dr. Mashkoor Choudhry at the University of Loyola Chicago. 
In this session, the discussion shifted from the effects of alcohol on lung injury to that of 
alcohol’s adverse effects on the liver, muscle, and brain. Dr. Patricia Molina of Louisiana 
State University Health Sciences Campus opened the session discussing alcohol–
neuroimmune interactions in a model of traumatic brain injury (TBI) via lateral fluid 
percussion (LFPI), and how neuroinflammation-mediated changes in behavior can lead to 
increased alcohol consumption (Crews et al., 2011). Dr. Molina and her group found that, 
using a model of chronic intermittent alcohol vapor exposure (CIEV), acute alcohol 
intoxication at the time of TBI resulted in greater impairment of short-term outcomes from 
TBI, including apnea, respiratory rate, and righting reflexes when compared to TBI 
delivered in the absence of alcohol. Additionally, following TBI in the absence of alcohol 
there was increased expression of IL-6, TNF-α, IL-1β, and MCP-1 mRNA in the ipsilateral 
cortex that resolved within 12 h, indicating short-term inflammation, whereas animals that 
were subjected to acute alcohol intoxication at the time of TBI displayed increased 
expression of these same proinflammatory cytokines 24 h post-injury suggesting that alcohol 
inhibited the resolution of the inflammation seen after TBI alone at the 24-h time point 
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(Teng & Molina, 2014). In another set of studies, it was found that when CIEV was 
administered after TBI (as opposed to earlier studies when acute alcohol intoxication was 
produced pre-injury), there was impaired neurologic recovery following TBI, which 
persisted even after CIEV was discontinued. TBI is associated with increased numbers of 
both astrocytes and microglia at the site of injury. However, Dr. Molina and her group 
observed a more dramatic elevation in the activation of astroglia and microglia after the 
combined insult of CIEV and TBI. Interestingly, the increase in neurological severity scores 
in animals exposed to CIEV after TBI positively correlated with increased 
neuroinflammation, suggesting a possible relationship between inflammation and behavioral 
changes. Neuroinflammation is now thought to be a correlate to many neurological and 
neurodegenerative diseases including Alzheimer’s, Parkinson’s, and depression/anxiety – 
diseases that are often associated with behavioral abnormalities. Because of this, it comes as 
no surprise that TBI, which results in sustained neuroinflammation, has also been associated 
with behavioral changes including increased alcohol and drug use. In a third set of studies, 
Dr. Molina and her group used a model of operant self-administration to examine changes in 
voluntary alcohol drinking following TBI. In these studies, it was observed that TBI caused 
escalated alcohol self-administration while maintaining increased astrogliosis and microglial 
activation. Finally, Dr. Molina and her group found that reducing neuroinflammation using 
an endocannabinoid degradation inhibitor (JZL184) administered once (16 mg/kg, 30 min 
post-TBI) could accelerate recovery from TBI by restoring the blood brain barrier, and 
limiting astrogliosis and microglial activation, and consequently improving behavioral 
outcomes. Collectively, these studies showed that alcohol exposure, whether acute at time of 
TBI or chronically following TBI, drastically increased neuroinflammation and impaired 
neurobehavioral recovery.
Kaku So-Armah, junior faculty at Boston University School of Medicine (mentored by Dr. 
Jeffrey Samet), shared his work investigating mechanisms of immunosenescence in a cohort 
of HIV-infected Russians with a recent history of heavy drinking prior to the initiation of 
antiretroviral therapy (ART). HIV-infected individuals may have a form of accelerated aging 
of the immune system (Deeks, 2011). Combined with HIV infection, the excessive alcohol 
use and viral hepatitis in this patient population could lead to poorer outcomes. Kaku 
analyzed 250 ART-naove HIV-infected Russians with a recent history of heavy drinking to 
determine whether liver injury, as assessed by a high fibrosis-4 (FIB4) score, had levels of T-
cell subsets consistent with immunosenescence, i.e., higher CD28−CD57+ and lower naove-
to-memory T-cell ratios for CD8+ and CD4+ T cells. Patients with elevated FIB4 scores had 
higher HIV viremia and HCV levels when compared to patients with lower FIB4 scores. 
However, in ART-naove HIV-infected Russians with a recent history of heavy drinking, 
elevated FIB4 scores did not correlate with these T-cell phenotypes associated with 
immunosenescence.
Trinidad Cisneros, a graduate student at Stanford University from the laboratory of Dr. 
Olivia Martinez, discussed the use of stem cell-derived hepatoblasts (SC-DH) as a potential 
alternative to treat alcoholic liver disease. The presentation highlighted a novel system for 
generating SC-DH from murine embryonic and induced pluripotent dual-reporter transgene+ 
stem cells, which has the added benefit of facilitating in vivo fate tracking and post-mortem 
evaluation. Both morphological and functional features of the hepatic lineage are present in 
Cannon et al. Page 6
Alcohol. Author manuscript; available in PMC 2017 August 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
SC-DH cells 13 days post-differentiation. Finally, following transplantation, the hepatoblasts 
survived and could be monitored by bioluminescent imaging. Together, these data provide 
evidence that stem cell-derived hepatoblasts could serve as a potential treatment for chronic 
alcoholic liver disease.
Dr. Guoshun Wang, from Louisiana State University Health Sciences Center in New 
Orleans, LA, shared his work on Glucocorticoid-Induced Leucine Zipper (GILZ) activation 
as a potential mechanism behind the immunosuppression seen following alcohol 
intoxication. GILZ acts as a glucocorticoid- (GC) responsive gene, which mediates anti-
inflammatory and immunosuppressive processes. It is well documented that alcohol abuse 
suppresses immunity, which allows for increased susceptibility to infection (Keshavarzian et 
al., 1999; Wang et al., 2014; Wood et al., 2013). Acute alcohol exposure at a binge-drinking 
level (50 mM or 100 mM) for 24 h induced GILZ expression in multiple cell types, 
including primary human airway epithelial cells, human umbilical vein endothelial cells 
(HUVEC), human peripheral blood monocytes, A549 cells, and BEAS-2B cells. The 
alcohol-upregulation of GILZ was through a non-canonical activation of glucocorticoid 
receptor signaling, which involved no glucocorticoids. Considering downstream effects of 
GILZ induced by alcohol, Dr. Wang went on to discuss how the elevated levels of the pro-
inflammatory cytokine TNF-α in LPS-stimulated Mono-mac-6 cells, a human monocyte cell 
line, was suppressed after exposure to alcohol. Depletion of GILZ via small RNA 
interference abolished the alcohol suppression of TNF-α production, suggesting that alcohol 
suppression of the monocyte response to LPS is mediated through induction of GILZ via 
non-canonical activation of the glucocorticoid receptor signaling.
Dr. Charles Lang of the Penn State College of Medicine rounded out the afternoon session, 
sharing his work on the effects of alcohol on the central nervous system (CNS), and how 
such effects regulate peripheral muscle metabolism. Chronic alcohol abuse leads to various 
biochemical and functional myopathies, and although the etiology remains unclear, data 
from the Lang lab clearly demonstrate the central role played by the inhibition of 
mechanistic target of rapamycin (mTOR)-kinase activity following both acute and chronic 
alcohol exposure. To assess the direct effects of alcohol on the CNS, alcohol was 
administered via intracerebroventricular (ICV) injection. Dr. Lang and his group showed that 
ICV alcohol exposure decreased skeletal muscle protein synthesis, and that this was a direct 
CNS effect of alcohol and not a result of alcohol metabolites. This was demonstrated using a 
non-metabolizable alcohol, t-butanol, and by inhibiting catalase, the enzyme responsible for 
metabolizing alcohol in the brain, which failed to trigger an alcohol-mediated decrease in 
skeletal muscle protein synthesis. The normal anabolic response of muscle protein synthesis 
to the amino acid leucine was also blunted in rats given ICV infusion of alcohol, and again 
the mechanism for this alcohol effect was mTOR-dependent. Since protein balance requires 
both de novo synthesis and protein degradation, Dr. Lang and his group examined effects of 
ICV alcohol infusion on muscle proteolysis and found an increased in proteolysis and 
proteosomal activity. The mechanism by which ICV alcohol infusion produces long-term 
changes in muscle protein synthesis did not involve continued stimulation of the 
hypothalamic-pituitary-adrenal axis, as adrenocorticotropic hormone levels were only 
transiently elevated. It was found, however, that ICV alcohol infusion selectively stimulated 
muscle sympathetic nerve activity. The neuronal mechanism regulating the protein synthesis 
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and degradation after ICV alcohol exposure still needs to be fully elucidated, but these data 
suggest that alcohol, through its effects on the CNS, has the ability to regulate the 
metabolism of peripheral organs in general and to stimulate muscle protein wasting in 
particular.
Summary
The 2015 AIRIG satellite symposium allowed presenters to share their novel data regarding 
how alcohol potentiates adverse pathophysiologies in the lung, brain, muscle, and liver. 
Experimental data shared at the meeting demonstrated that alcohol increases the severity of 
respiratory syndromes, such as asthma-like symptoms and acute respiratory distress 
syndrome, and the susceptibility to lung infection, while it limits normal lung repair 
mechanisms following injury. Moreover, alcohol induced excessive neuroinflammation and 
had a negative impact on TBI. Additionally, alcohol exposure can lead to 
immunosuppression, which can increase susceptibility to infection in the liver and other 
organ systems. Together, these data not only demonstrate the widespread adverse effects of 
alcohol on disease progression, but also show the continued need for the inclusion of both 
short-term acute and chronic alcohol models, as many questions remain unanswered.
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